Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 25 February 2022
- Opportunity publication date
- 25 January 2022
- Category
- 33600000: Ph
- Value of contract
- to be confirmed
- Your guide to exporting
Description
The subject of the present public procurement procedure is successive supplies of drugs and pharmaceuticals to the Hospital Pharmacy for the needs of "Pro-Medica" in Ełk, of which the detailed description and quantities are specified in Appendix No. 3 to the SWZ - i.e. the assortment and price form.
Drugs I Drugs II Drugs III Drugs IV Drugs V Drugs VI Drugs VII Drugs VIII Drugs IX Drugs X Drugs XI Drugs XII MEDICINAL ABSORBED BLOCK HEPARINES XIII MIDAZOLAM METHYLTHIONINIUM CHLORIDE METAMIZOLE SODIUM ALTEPLASE METHYLTHIONINIUM CHLORIDE METAMIZOLE SODIUM ALTEPLASE PARACETAMOL PARACETAMOL NARKOTICS INHALED ANESTHETICS AND INHALED ANESTHETICS II ALBUMIN ALBUMIN/IMMUNOGLOBULIN IMMUNOGLOBULIN I IMMUNOGLOBULIN II IMMUNOGLOBULIN III PORACTANT ALFA OMEPRAZOLE / PANTOPRAZOLE DOBUTAMINE CONTRAST AGENTS ATOSIBAN CITICOLINUM INSULIN I INSULIN II INFLUENZA VACCINE HUMAN PAPILLOMA VIRUS VACCINE ANTIBIOTICS I ANTIBIOTICS II ANTIBIOTICS V CIPROFLOXACIN LINEZOLID AMPHOTERICIN CYTOSTATIC CHEMOTHERAPY DRUGS OMALIZUMABUM MEPOLIZUMABUM PALIVIZUMABUM PARENTERAL NUTRITION I ( NEONATES) PARENTERAL NUTRITION II PARENTERAL NUTRITION III PARENTERAL NUTRITION IV PARENTERAL NUTRITION V PARENTERAL NUTRITION V PARENTERAL NUTRITION ENTERAL NUTRITION I ENTERAL NUTRITION II ENTERAL NUTRITION III ENTERAL NUTRITION MILK INFUSION LIQUIDS I INFUSION LIQUIDS II INFUSION LIQUIDS III INFUSION LIQUIDS IV INFUSION LIQUIDS V INFUSION LIQUIDS VI HEMOFILTRATION FLUIDS PRESCRIPTION DRUGS IMPORTATION TARGET
- Opportunity closing date
- 25 February 2022
- Value of contract
- to be confirmed
About the buyer
- Address
- "Pro-Medica" w Ełku Sp. z o.o. ul.Baranki 24 Ełk 19-300 Poland
- Contact
- przetargi@szpital.elk.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.